Revvity Cost of Goods Sold 2010-2025 | RVTY
Revvity annual/quarterly cost of goods sold history and growth rate from 2010 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Revvity cost of goods sold for the quarter ending March 31, 2025 was $0.289B, a 1.92% decline year-over-year.
- Revvity cost of goods sold for the twelve months ending March 31, 2025 was $1.212B, a 0.04% decline year-over-year.
- Revvity annual cost of goods sold for 2024 was $1.217B, a 0.54% increase from 2023.
- Revvity annual cost of goods sold for 2023 was $1.211B, a 8.4% decline from 2022.
- Revvity annual cost of goods sold for 2022 was $1.322B, a 5.15% decline from 2021.
| Revvity Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $1,217 |
| 2023 | $1,211 |
| 2022 | $1,322 |
| 2021 | $1,394 |
| 2020 | $933 |
| 2019 | $1,488 |
| 2018 | $1,437 |
| 2017 | $1,183 |
| 2016 | $1,101 |
| 2015 | $1,141 |
| 2014 | $1,135 |
| 2013 | $1,181 |
| 2012 | $1,144 |
| 2011 | $1,071 |
| 2010 | $943 |
| 2009 | $850 |
| Revvity Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $289 |
| 2024-12-31 | $317 |
| 2024-09-30 | $299 |
| 2024-06-30 | $306 |
| 2024-03-31 | $295 |
| 2023-12-31 | $312 |
| 2023-09-30 | $298 |
| 2023-06-30 | $307 |
| 2023-03-31 | $293 |
| 2022-12-31 | $305 |
| 2022-09-30 | $305 |
| 2022-06-30 | $344 |
| 2022-03-31 | $368 |
| 2021-12-31 | $-10 |
| 2021-09-30 | $338 |
| 2021-06-30 | $543 |
| 2021-03-31 | $523 |
| 2020-12-31 | $-212 |
| 2020-09-30 | $437 |
| 2020-06-30 | $364 |
| 2020-03-31 | $344 |
| 2019-12-31 | $407 |
| 2019-09-30 | $365 |
| 2019-06-30 | $375 |
| 2019-03-31 | $341 |
| 2018-12-31 | $380 |
| 2018-09-30 | $342 |
| 2018-06-30 | $363 |
| 2018-03-31 | $352 |
| 2017-12-31 | $334 |
| 2017-09-30 | $285 |
| 2017-06-30 | $289 |
| 2017-03-31 | $274 |
| 2016-12-31 | $290 |
| 2016-09-30 | $266 |
| 2016-06-30 | $283 |
| 2016-03-31 | $263 |
| 2015-12-31 | $229 |
| 2015-09-30 | $309 |
| 2015-06-30 | $311 |
| 2015-03-31 | $292 |
| 2014-12-31 | $233 |
| 2014-09-30 | $299 |
| 2014-06-30 | $308 |
| 2014-03-31 | $295 |
| 2013-12-31 | $313 |
| 2013-09-30 | $289 |
| 2013-06-30 | $299 |
| 2013-03-31 | $280 |
| 2012-12-31 | $303 |
| 2012-09-30 | $279 |
| 2012-06-30 | $283 |
| 2012-03-31 | $279 |
| 2011-12-31 | $300 |
| 2011-09-30 | $254 |
| 2011-06-30 | $270 |
| 2011-03-31 | $247 |
| 2010-12-31 | $259 |
| 2010-09-30 | $233 |
| 2010-06-30 | $232 |
| 2010-03-31 | $218 |
| 2009-12-31 | $144 |
| 2009-09-30 | $208 |
| 2009-06-30 | $250 |
| 2009-03-31 | $247 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.693B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $134.596B | 25.24 |
| CVS Health (CVS) | United States | $77.976B | 9.69 |
| Elevance Health (ELV) | United States | $62.251B | 8.37 |
| Cencora (COR) | United States | $56.726B | 19.74 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $20.342B | 16.50 |
| Natera (NTRA) | United States | $19.203B | 0.00 |
| BioMerieux (BMXMF) | France | $16.276B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.050B | 0.00 |
| Solventum (SOLV) | United States | $12.516B | 13.25 |
| ICON (ICLR) | Ireland | $11.276B | 10.48 |
| Viatris (VTRS) | United States | $10.446B | 3.59 |
| Medpace Holdings (MEDP) | United States | $8.878B | 22.97 |
| Sonic Healthcare (SKHHY) | Australia | $8.792B | 0.00 |
| Avantor (AVTR) | United States | $8.409B | 12.22 |
| HealthEquity (HQY) | United States | $8.395B | 36.77 |
| Charles River Laboratories (CRL) | United States | $7.357B | 14.42 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.197B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.928B | 29.02 |
| BrightSpring Health Services (BTSG) | United States | $3.465B | 31.79 |
| Sotera Health (SHC) | United States | $3.125B | 17.76 |
| Surgery Partners (SGRY) | United States | $2.866B | 37.27 |
| Concentras Parent (CON) | United States | $2.557B | 14.78 |
| Alignment Healthcare (ALHC) | United States | $2.473B | 0.00 |
| Organon (OGN) | United States | $2.457B | 2.61 |
| GeneDx Holdings (WGS) | United States | $2.235B | 86.09 |
| Progyny (PGNY) | United States | $1.966B | 43.28 |
| PACS (PACS) | United States | $1.771B | 0.00 |
| Premier (PINC) | United States | $1.723B | 13.08 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Ardent Health (ARDT) | United States | $1.566B | 6.68 |
| Teladoc Health (TDOC) | United States | $1.461B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.232B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.086B | 8.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.886B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.711B | 6.66 |
| CareDx (CDNA) | United States | $0.710B | 11.09 |
| Nutex Health (NUTX) | United States | $0.618B | 9.35 |
| Embecta (EMBC) | United States | $0.601B | 4.05 |
| So-Young (SY) | China | $0.581B | 0.00 |
| SBC Medicals (SBC) | United States | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| LifeMD (LFMD) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| Omada Health (OMDA) | $0.466B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.340B | 28.00 |
| Oncology Institute (TOI) | United States | $0.304B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.149B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.066B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.042B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |